About
Nemus is a biopharmaceutical company focused on the discovery, development, and commercialization of cannabis-based therapeutics for global markets, utilizing proprietary technology licensed from the University of Mississippi to optimize clinical effects and limit adverse events.
Explore Nemus's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.